Research · AI News ·
How AI is shortening drug discovery timelines in China
Insilico Medicine says it has used AI and laboratory research in China to reduce some drug candidate development timelines to about one year. CEO Alex Zhavoronkov said its fastest program reached candidate nomination in nine months, compared with a typical 13 months.